首页 | 本学科首页   官方微博 | 高级检索  
     


Solifenacin is effective and well tolerated in patients with neurogenic detrusor overactivity: Results from the double‐blind,randomized, active‐ and placebo‐controlled SONIC urodynamic study
Authors:G. Amarenco  M. Sutory  R. Zachoval  M. Agarwal  G. Del Popolo  R. Tretter  G. Compion  D. De Ridder
Affiliation:1. H?pital Tenon, Service De Neuro‐Urologie Et D'Explorations Perineales, Paris, France;2. Urological Department of Traumatological Clinic, Traumatological Hospital, School of Medicine, Masaryk University, Brno, Czech Republic;3. Thomayer Hospital and 1st and 3rd Faculty of Medicine, Charles University, Prague, Czech Republic;4. Cardiff University and University Hospital of Wales, Cardiff, United Kingdom;5. Department of Neuro‐Urology, Careggi University Hospital, Florence, Italy;6. Astellas Pharma Europe, Global Data Science, Leiden, The Netherlands;7. Department of Medical Affairs, Formerly at Astellas Pharma Europe, Chertsey, United Kingdom;8. Department of Urology, KU Leuven, University Hospitals Leuven, Leuven, Belgium
Abstract:
Keywords:cystometry  incontinence quality‐of‐life (I‐QoL)  multiple sclerosis (MS)  neurogenic detrusor overactivity (NDO)  solifenacin  SONIC  spinal cord injury (SCI)  urodynamic
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号